http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104586771-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate | 2013-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104586771-B |
| titleOfInvention | A kind of tamsulosin hydrochloride sustained-release pellet preparation |
| abstract | A kind of tamsulosin hydrochloride sustained-release pellet preparation, the micropill include sustained release capsule core, sustained-release coating layer and the enteric coat layer of tamsulosin hydrochloride, and it is capsule.The tamsulosin hydrochloride sustained-release pellet preparation of the present invention employs skeleton sustained release, film-controlled slow-release and the triple slow release method Drug controlled releases of enteric coating, obtained tamsulosin hydrochloride sustained-release micro-pill capsules reduce the adverse reaction caused by tamsulosin hydrochloride largely absorbs in a short time by controlling the release from stomach to intestines.Preparation method technique of the present invention is simple, can stablize and efficiently control the release of tamsulosin hydrochloride in vivo. |
| priorityDate | 2013-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.